Annual report pursuant to Section 13 and 15(d)

Note 13 - Subsequent Events

v3.7.0.1
Note 13 - Subsequent Events
12 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Subsequent Events [Text Block]
Note
13.
Subsequent Events:
 
In
July 2017,
management determined that CyVek achieved the required revenue threshold for the additional consideration payment discussed in Note
4
resulting in a payment of
$34.0
million to the former owners.
 
On
September 5, 2017,
Bio-Techne acquired Trevigen Inc for approximately
$11.0
million. The purchase accounting for this acquisition is in progress.